The Supreme Court issued an order on May 14, 2026, staying a Fifth Circuit ruling that would have restricted access to mifepristone, effectively allowing telehealth prescriptions and mail-order delivery to continue nationwide while litigation proceeds. Sean Rameswaram of Today, Explained noted the volatility of the past weeks, stating, "On May 1st, a district appeals court temporarily banned access to telehealth abortion and pills by mail nationwide. So for a few days, a lot of people in the country were like, 'Uh...'," before highlighting that the high court eventually intervened.
While the legal battle remains unresolved in lower courts, podcasts are highlighting the creative workarounds states are pursuing to protect access. Today, Explained reported on the role of shield laws, with a guest contributor noting that states like New York now "permit doctors and clinics to omit identifying information from pill bottles so that a 12-pill bottle of mifepristone can arrive in Louisiana without indicating who sent it." This strategy underscores the deepening divide between state-level protections and the federal legal challenges brought by states like Louisiana.
The consensus among commentators remains focused on the medical necessity of maintaining current access points. Today, Explained guests argued that "leaving all medically sound options on the table, including dispensing mifepristone via mail or at local pharmacies, is critical." As the case moves forward, the focus will likely shift toward whether these temporary procedural stays can hold up against the underlying arguments regarding the FDA's original approval process.
